The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


300 milligram(s) Orodispersible tablet

Eisai GmbHEU/1/04/307/020-021

Main Information

Trade NameZonegran
Active SubstancesZonisamide
Strength300 milligram(s)
Dosage FormOrodispersible tablet
Licence HolderEisai GmbH
Licence NumberEU/1/04/307/020-021

Group Information

ATC CodeN03AX Other antiepileptics
N03AX15 zonisamide


Licence Issued27/07/2010
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing Status


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back